Modulo Bio specializes in the development of digital biological mechanisms aimed at expediting the discovery of therapeutic targets by leveraging autoimmunity. The company provides stem cell manipulation to create human microglia-centered neuroimmune microenvironments from stem cells for the purpose of controlling and assessing the neuroimmune system in cellular models and from patients' samples. This allows healthcare enterprises to explore new avenues for treating neurodegenerative conditions.
Modulo Bio
Headquarters
United States of America